Tag mmj

Hearing in Olympia to Revisit Hazy Medical Marijuana Law

Eight months after Gov. Chris Gregoire gutted the state medical-marijuana law with a partial veto, dispensaries have feasted or starved based on the real-estate axiom: location, location, location. A new bill in Olympia to legalize nonprofit dispensers could lead to a statewide dispensary boom.

By Jonathan Martin

Chris Cody tries to be a good neighbor in White Center, joining in a Christmas toy drive and local art walks, and keeping the window of his medical-marijuana dispensary as discreet as possible.

He maintains a low profile in part because his shop, Herban Legends, is a block outside the marijuana-friendly Seattle city limits. Inside Seattle, marijuana dispensaries flourish. Outside Seattle, there is no protective regulation.

“It’s definitely tricky, causing for more than a little anxiety,” said Cody, a 31-year-old carpenter.

Eight months after Gov. Chris Gregoire gutted the state medical-marijuana law with a partial veto, dispensaries have feasted or starved based on the real-estate axiom: location, location, location.

Seattle, Tacoma and a handful of other cities recognize storefront shops as resources for medical-marijuana patients. Most don’t, though, citing a muddled state law or the federal marijuana prohibition.

Legislators, still pained by the veto but pressed by cities to fix the mess, are preparing to try again. A hearing is scheduled Wednesday on SB 6265, a bill proposed by medical marijuana’s champion in Olympia, Sen. Jeanne Kohl-Welles, D-Seattle, to legalize nonprofit dispensers and kick regulation to cities.

If passed, the plan could clear a legal haze hovering over storefront shops. Although not explicitly allowed under state law, they have operated via legal loopholes, most recently under a broad interpretation of the term “collective garden.”

And a new law could open the door to a statewide dispensary boom, especially in some larger cities, such as Bellevue, that have refused to allow them.

“I don’t think it’s fair that Seattle and Tacoma have people coming from all over the place to purchase marijuana in their jurisdiction,” Kohl-Welles said.

The bill sets off what is likely to be a big year for marijuana-policy debates. Lawmakers are expected to send to voters in November an initiative that would legalize and tax recreational-marijuana sales.

Whether lawmakers have the stomach — or the time — to legalize dispensaries is unclear in a session already crowded with a budget deficit of roughly $1.5 billion and a gay-marriage proposal.

Police oppose dispensaries, and federal authorities recently raided some shops.

Cody, who has invested about $20,000 in Herban Legends, said he is patient, if nervous. “We’re still in this limbo,” he said. “As time goes on, more people will come on board. Things take awhile, and they should.”

Shops as gardens

After Gregoire’s partial veto of a 2001 bill that would have set up statewide regulation of dispensaries, storefront shops gravitated to perceived safe havens, particularly Seattle.

Sections of the bill that survived the veto authorized 45-plant patient gardens. Those provisions were not intended to create storefront dispensaries, but shops nonetheless reorganized as networks of gardens.

Cities have made their own rules, many enacting moratoriums. Issaquah requires a background check to obtain a regulatory license, and Shoreline this month mandated buffer zones between dispensaries, which are also called “collectives.”

The legal uncertainty hasn’t ended bigger dreams.

Bellevue real-estate broker Tom Gordon, who has helped 10 dispensaries find storefronts, said good commercial parcels can attract inquiries from 40 to 60 people looking to open dispensaries. Some are Californians or Coloradans who “tell you it’s like the Wild West out here, with less competition and a good taxing structure,” Gordon said.

“I think we’re only at 20-30 percent of capacity,” Gordon said, “but you can’t find the sites,” in part because few landlords are willing to lease to dispensaries.

Storefront dispensaries began popping up at least 10 years after Washington voters in 1998 authorized medical marijuana for qualified patients. In November, federal authorities raided 10 shops, including several in Seattle, accused some of using state law to hide money laundering and, in one case, a backdoor sale of 5 pounds of pot going to the Midwest.

Philip Dawdy of the Washington Alternative Medicine Alliance, a medical-marijuana group, estimates about 135 dispensaries are open now, half in Seattle. He said the new proposal in Olympia is needed to end “a patchwork of regulations.”

“Our goal is to have reasonably clear state law that is unambiguous and won’t lead to the feds making threats,” Dawdy said.

The state Department of Revenue (DOR), which last year warned dispensers they must tax their sales, said 15 marijuana-related business paid a total of $243,600 in state and local taxes in the first nine months of 2011, including $52,600 in local sales taxes.

That’s nearly tenfold as much as the marijuana industry paid in 2010, “but it is unlikely it represents all the taxable sales taking place,” DOR spokesman Mike Gowrylow said.

Resistance to registry

Although dispensaries say they intend to help those who need marijuana, patients are likely to oppose the legislation Wednesday.

The new bill would guarantee arrest protection if patients join a voluntary registry, an idea that is anathema to some. Those not signed up would have lesser protection — an “affirmative defense,” if criminally charged.

“I don’t understand why I need to register. It seems like a lot of headache, paperwork and bureaucracy,” said Ric Smith, a patient advocate who is on kidney dialysis.

The registry is intended to mute law-enforcement opposition to dispensaries. Police groups favor registries, and Kohl-Welles said a registry was part of a deal to reach “the lowest common denominator of support.”

Cities have clamored for lawmakers to clarify dispensaries’ status after Gregoire’s veto. The new plan would give cities in the nine largest counties the ability to ban dispensaries and would give cities in the 30 other, smaller counties the right to opt in.

While Bellevue is among communities that have denied licenses on the basis that marijuana is illegal, the city “may support” the new bill once the City Council sees it, city spokesman David Grant said.

Tacoma, at one point, had more dispensaries than pharmacies. The city since has installed a moratorium, pending a review of its policy.

“I’m not sure you should be allowed to ban all citizen access to something the citizens of Washington have said they want to allow,” Tacoma lobbyist Randy Lewis said.

Gregoire’s partial veto last year was based, she said, on a fear that federal authorities could hold state employees liable for regulating dispensaries. Executive policy adviser Jason McGill said the governor finds “nothing objectionable” about the new bill because state employees wouldn’t be involved.

Even with Gregoire’s support, the proposal’s prospects are unclear.

Sen. Jerome Delvin, R-Richland, who co-sponsored this year’s dispensary bill, fears lawmakers may be too busy with the budget and other issues.

“I think it falls behind some other pretty big policy discussions,” said Delvin, a retired police officer.

If lawmakers act, though, expect more dispensaries. Jake George and his wife, Lydia, a paralegal, opened GreenLink Collective in Seattle’s Sodo area after an expensive, six-month fight with Issaquah to open there.

“From our experience, there are people who are curious and want to be involved,” said George, 32, a former electronics salesman. “If you take the risk out, you’d see an influx.”

Share

Mind Candy

Found this image on sushibandit.com and figured that a patient or two would appreciate it… if you’re not a patient, please look away – this is NOT for your eyes. Be happy that you have your health ;)

Direct link ——> http://sushibandit.com/wp-content/uploads/2011/12/vortex9.gif

Share

Marijuana study for veterans with trauma faces hurdle

Brian Vastag / The Washington Post

Posted: 10/03/2011 06:46:07 AM MDT

WASHINGTON — Getting pot on the street is easy. Just ask the 17 million Americans who smoked the federally illegal drug in 2010.

Obtaining weed from the government? That’s a lot harder.

In April, the Food and Drug Administration approved a first-of-its kind study to test whether marijuana can ease the nightmares, insomnia, anxiety and flashbacks common in combat veterans with post-traumatic stress disorder.

But now another branch of the federal government has stymied the study. The Health and Human Services Department is refusing to sell government-grown marijuana to the nonprofit group proposing the research, the Multidisciplinary Association for Psychedelic Studies.

The agency did leave the door open to eventually providing 13 pounds of the weed, which is grown at the University of Mississippi. But the HHS committee that rejected the request provided such conflicting criticisms that the person directing the study, MAPS Director Rick Doblin, is unsure how to address their concerns.

“Their goal at higher levels, I think, is to block the study,” said Doblin, who for 25 years has been jumping through regulatory hoops to launch human studies of marijuana, LSD and MDMA, known as ecstasy, which are all illegal.

The HHS official in charge of the review, Sarah A. Wattenberg, declined to answer questions when reached by phone. Tara Broido, a spokeswoman for the agency, wrote in an e-mail that “the production and distribution of marijuana for clinical research is carefully restricted under a number of federal laws and international commitments.”

The study proposes testing five doses of marijuana in 50 combat veterans with PTSD whose symptoms have not improved despite conventional treatments — typically talk therapy, antidepressants and anti-anxiety medicines.

Many veterans already use marijuana to calm their PTSD, said Mary Tendall, a licensed therapist in Nevada City, Calif., who has treated “hundreds” of traumatized Vietnam, Afghanistan and Iraq veterans.

“It does mellow out the triggered response in a certain population,” said Tendall, referring to hair-trigger anxiety reactions. “But with some, it made them very, very paranoid — it had the opposite effect.”

For Paul Culkin, a 32-year-old Army veteran living in Albuquerque, small daily doses of pot offer a release from sleepless nights and high anxiety.

In November 2004, Culkin suffered neck injuries when a car bomb exploded 30 feet from him in southern Kosovo.

When Culkin returned home, he had “really bad nightmares and insomnia, lots of cold sweats,” he said. He rarely left the house.

Culkin began taking anti-depressants, and he eventually received a medical separation from the Army. He now receives Veterans Affairs disability payments.

New Mexico is one of two states, along with Delaware, that explicitly allows the use of marijuana to treat PTSD. Culkin got state approval in 2008 to use it. “It really gets rid of your nightmares if you smoke before you go to bed,” he said. “You feel like you got some rest finally.”

Doblin thinks marijuana can help many more veterans. A 2004 study in the New England Journal of Medicine estimated that 18 percent of returning Iraq combat veterans had PTSD. And a 2008 report from the Rand Corp., a government contractor, estimated that up to 225,000 veterans will return from the Middle East clinically traumatized.

Medical marijuana is legal in 16 states and the District of Columbia. But obtaining it from the federal government for research requires surmounting an extra regulatory hurdle that is not required for any other drug.

That’s because one government agency, the National Institute on Drug Abuse, controls the nation’s supply of research marijuana. Any non-government researcher wanting access to it needs to satisfy the special HHS committee.

On Sept. 14, Wattenberg, the official in charge of the committee, wrote to Doblin detailing “a number of concerns related to the proposal’s approach, feasibility, and documentation of human subjects’ protection.”

But written comments from the five committee members paint a jumbled picture of sometimes contradictory concerns.

One member wrote that the study should exclude veterans who have previously smoked marijuana. And another committee member asked for the opposite, that the study should only include people who have smoked the drug, as those naive to it might suffer anxiety or panic attacks.

A third reviewer wrote that study participants should be monitored closely — presumably in a hospital — rather than letting them smoke the marijuana at home.

“Turning this into an in-patient study ends the study,” Doblin said. “Nobody will live in-patient for three months, and that increases the study costs astronomically.”

Other comments expressed skepticism that the marijuana in the study — given in weekly batches — could be kept from getting “diverted,” meaning given or sold to non-participants.

In a phone interview, Doblin pointed out that the study’s design satisfied FDA drug-diversion officials.

Participants will be required to videotape their every interaction with the weed, and will have to return any they do not smoke. In addition, a second person will have to witness the smoking and check in with the researchers weekly.

Doblin plans to modify the study and resubmit it to the committee, which will have to unanimously agree before the marijuana sale can move forward, Broido said. But even if HHS approves, another bureaucracy looms — that of the Drug Enforcement Administration. The nation’s drug cops also have to approve the research.

“It’s a long road,” Doblin said. “But it’s worth it. We’re the mythical American trying to play by the rules.”

Original Posting: http://www.dailycamera.com/nation-world-news/ci_19026223?IADID=Search-www.dailycamera.com-www.dailycamera.com

Share

Evolving List of Cannabis Terms

Clone: an antiquated (pre-July 1, 2011) way of referring to an ‘immature plant’; clones are cuttings from a cannabis plant that grow roots and have the same genetics as the host plant that it was taken from.

 

Cola: the top of a flowering plant, where there will be one large bud.  Colas often ave higher THC content than the rest ofthe flowering plant.

 

Flowering: cannabis is dioecious; each plant produces either male or female flowers, and is considered either a male or female plant.  Male plants usually start to flower about one month before the female; however, there is sufficient overlap to ensure pollination.

 

Kief: is not spelled KEIF and that really bothers me… kief is the loose, dried resin glands (trichomes) of cannabis which may accumulate on containers, in grinders, or be removed with a kiefing screen or sieve.  The term originates from the Egyptian dialect of Arabic, where the word can be translated as “being buzzed” or “liking to get high”.  Kief contains a much higher concentration of desired psychoactive ingredients, primarily THC, than ordinary preparations of cannabis bud from which it is derived.

 

Leaves: there are 3 types of leaves on a cannabis plant.  Large shade, or fan, leaves have low THC and are rarely used in other applications.  Grow tips are small, tender leaves formed during vegetation and are more potent than fan leaves.  Thirdly, trim leaves are generally coated with a layer of trichomes and can be used to make concentrates / hash.

 

Seeds: an alternative to growing with immature plants.  Seeds can be feminized, which will generally produce the most sought after female cannabis plants.

 

Trichomes: the resin glands produced by the cannabis plant that contain the majority of THC, CBN & CDB.  They can be clear, cloudy, or amber, depending on the curing and harvest times.  They resemble small stalks with bulbous heads and range from 15 to 500 microns in size.  To the naked eye, trichomes give cannabis the appearance of being covered with a white dust.

 

Vegetative Growth: the period of maximum growth in a cannabis plant.  The plant can grow no faster than the rate that its leaves can produce energy for new growth.  Each day more leaf tissue is created, increasing the overall capacity for growth.  The vegetative stage is usually completed in the third to fifth month of growth.

 

Lots more to come…

 

Share

Glaucoma MMJ Research Articles

I found a handful of articles (PDF downloads are available below) relating to treating glaucoma with cannabis, and thought it would be good to post ‘em here. Feel free to send a link if full & free public access to an unmentioned article is available and I will add it to the list for sure.

===================

Marijuana Smoking vs Cannabinoids for Glaucoma Therapy

http://archopht.ama-assn.org/cgi/reprint/116/11/1433

 

Glaucoma, hypertension, and marijuana

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2552967/pdf/jnma00062-0013.pdf

 

The human eye expresses high levels of CB1 cannabinoid receptor mRNA and protein

http://www.fuoriluogo.it/medicalcannabis/documenti/Porcella-cb1%20in%20human%20eye.pdf


Marijuana smoking and reduced pressure in human eyes: drug action or epiphenomenon?

http://www.iovs.org/content/14/1/52.full.pdf

 

Medical marijuana and the developing role of the pharmacist

http://axon.psyc.memphis.edu/~charlesblaha/7705/Papers_08/samantha_daniel_medical_marijuana.pdf

 

(THC) in the treatment of endstage open-angle glaucoma

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1358964/pdf/12545695.pdf

 

Recent developments in the therapeutic potential of cannabinoids

http://prhsj.rcm.upr.edu/index.php/prhsj/article/view/404/280

 

Cannabinoids in medicine: A review of their therapeutic potential

http://www.omma1998.org/Cannabinoids%20in%20medicine.%20A%20review%20of%20their%20therapeutic%20potential.pdf

 

Marijuana (Cannabis) as Medicine

http://www.cannabis-med.org/data/pdf/2001-01-1.pdf

Share
Get Adobe Flash playerPlugin by wpburn.com wordpress themes

Copyright © The Releaf Center Blog
Informing & Entertaining Since 2009